Literature DB >> 26742516

Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Zohara Sternberg1.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating central nervous system (CNS) disease with an uncertain etiology. MS is heterogeneous, involving multiple clinical pathologies, including neurodegeneration, depression, fatigue and sleep disorders, migraine, osteoporosis and cerebral hemodynamic impairments. The underlying causes of these pathologies remain mostly unknown. Based on the accumulating evidence derived from our studies and those of other investigators, we propose that the dysregulation in the neurovisceral integration of cardiovascular modulation can lead to many MS-related clinical symptoms. We show that MS inflammatory and neurodegenerative processes are intertwined with the aforementioned clinical morbidities and are collectively the manifestations of cardiovascular autonomic nervous system (ANS) dysfunction. The strategies for improving sympathovagal balance would likely prevent and minimize many MS-related clinical symptoms, improving patients' quality of life. Similar strategies could be applied to other autoimmune and neurodegenerative diseases where autonomic imbalance plays a role.

Entities:  

Keywords:  Blood pressure; Cerebral autoregulation; Cerebral blood flow; Dysautonomia; Heart rate variability; Hypoxic ischemia; Inflammation; Internal jugular vein; Neurodegeneration; Trigeminocardiac reflexes; Vascular remodeling; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 26742516     DOI: 10.1007/s12035-015-9599-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  177 in total

1.  Clinical characteristics of responders to interferon therapy for relapsing MS.

Authors:  Pablo Villoslada; Jorge R Oksenberg; Jordi Rio; Xavier Montalban
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

2.  Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

Authors:  Hillel Panitch; Aaron Miller; Donald Paty; Brian Weinshenker
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

3.  [Pregnancy-induced changes in adrenergic receptors].

Authors:  R Tschada; A Hettenbach; F Melchert; P Alken
Journal:  Z Geburtshilfe Perinatol       Date:  1991 Jul-Aug

Review 4.  Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).

Authors:  Amy M Burrell; Adam E Handel; Sreeram V Ramagopalan; George C Ebers; Julia M Morahan
Journal:  Discov Med       Date:  2011-03       Impact factor: 2.970

Review 5.  The role of vagal function in the risk for cardiovascular disease and mortality.

Authors:  Julian F Thayer; Richard D Lane
Journal:  Biol Psychol       Date:  2006-12-19       Impact factor: 3.251

6.  A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.

Authors:  Samia J Khoury; Brian C Healy; Pia Kivisäkk; Vissia Viglietta; Svetlana Egorova; Charles R G Guttmann; Josiah F Wedgwood; David A Hafler; Howard L Weiner; Guy Buckle; Sandra Cook; Susheel Reddy
Journal:  Arch Neurol       Date:  2010-09

7.  BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

Authors:  Christine Stadelmann; Martin Kerschensteiner; Thomas Misgeld; Wolfgang Brück; Reinhard Hohlfeld; Hans Lassmann
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

Review 8.  Cerebrospinal fluid stasis and its clinical significance.

Authors:  James M Whedon; Donald Glassey
Journal:  Altern Ther Health Med       Date:  2009 May-Jun       Impact factor: 1.305

9.  Fatigued patients with multiple sclerosis can be discriminated from healthy controls by the recordings of a newly developed measurement system (FAMOS): a pilot study.

Authors:  Fei Yu; Arne Bilberg; Ulrik Dalgas; Egon Stenager
Journal:  Disabil Rehabil Assist Technol       Date:  2012-05-15

10.  Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.

Authors:  Meng Law; Amit M Saindane; Yulin Ge; James S Babb; Glyn Johnson; Lois J Mannon; Joseph Herbert; Robert I Grossman
Journal:  Radiology       Date:  2004-06       Impact factor: 11.105

View more
  3 in total

1.  Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis.

Authors:  Mario Habek; Luka Crnošija; Mila Lovrić; Anamari Junaković; Magdalena Krbot Skorić; Ivan Adamec
Journal:  Clin Auton Res       Date:  2016-07-22       Impact factor: 4.435

2.  Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek
Journal:  Clin Auton Res       Date:  2018-09-12       Impact factor: 4.435

3.  Cardiovascular Autonomic Dysfunction and Falls in People With Multiple Sclerosis: Is There a Link? An Opinion Article.

Authors:  Tobia Zanotto; Manuel E Hernandez; Cristina N Medrano; Kenneth R Wilund; Jacob J Sosnoff
Journal:  Front Neurosci       Date:  2020-12-07       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.